Vanguard Group Inc. Sells 36,382 Shares of Dolby Laboratories $DLB

Vanguard Group Inc. decreased its position in shares of Dolby Laboratories (NYSE:DLB) by 0.5% during the 4th quarter, HoldingsChannel reports. The fund owned 7,720,542 shares of the electronics maker’s stock after selling 36,382 shares during the period. Vanguard Group Inc. owned about 0.08% of Dolby Laboratories worth $495,813,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. First Horizon Corp bought a new position in Dolby Laboratories in the third quarter valued at about $25,000. Hantz Financial Services Inc. grew its holdings in shares of Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares during the last quarter. Mather Group LLC. acquired a new position in shares of Dolby Laboratories in the third quarter valued at approximately $38,000. Rothschild Investment LLC raised its holdings in Dolby Laboratories by 4,046.7% in the 3rd quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after buying an additional 607 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new position in Dolby Laboratories in the 3rd quarter valued at approximately $50,000. Institutional investors own 58.56% of the company’s stock.

Analyst Ratings Changes

DLB has been the topic of a number of research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Barrington Research reiterated an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a report on Monday, April 27th. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research note on Friday, January 30th. Finally, Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $90.75.

Dolby Laboratories Stock Performance

NYSE:DLB opened at $59.16 on Wednesday. The company has a market capitalization of $5.65 billion, a PE ratio of 23.38 and a beta of 0.86. The company has a 50 day simple moving average of $62.48 and a two-hundred day simple moving average of $64.42. Dolby Laboratories has a fifty-two week low of $55.73 and a fifty-two week high of $78.28.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. During the same quarter last year, the business earned $1.34 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Research analysts predict that Dolby Laboratories will post 3.17 EPS for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be issued a $0.36 dividend. The ex-dividend date is Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.4%. Dolby Laboratories’s payout ratio is presently 56.92%.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CAO Ryan Nicholson sold 2,667 shares of the company’s stock in a transaction on Friday, February 13th. The shares were sold at an average price of $66.38, for a total transaction of $177,035.46. Following the sale, the chief accounting officer owned 36,956 shares of the company’s stock, valued at approximately $2,453,139.28. This represents a 6.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total value of $198,420.00. Following the sale, the senior vice president owned 83,218 shares of the company’s stock, valued at approximately $5,504,038.52. The trade was a 3.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 37.93% of the stock is owned by insiders.

Dolby Laboratories Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.